SHYCOCAN

SHYCOCAN™ Prototype/Test Devices

SHYCOCAN™ Prototype/Test Devices

SHYCOCAN® - Scalene Hypercharge Corona Canon air-purifier is intended to disable air and surface-borne coronaviruses

  • Scalene Hypercharge Corona Canon (SHYCOCAN®) is intended to disable certain viruses including coronaviruses, the virus associated with COVID-19.

  • It is NOT a plasma generator, ionizer, UV/Ozone disinfection, or HEPA filter.

  • The Device is a simple, portable, sensitive methodology to disable coronaviruses.

  • Can complement hand washing, sanitizing and using PPEs.

  • The negative charge-seeking guidance mechanism of the virus’ Spike Protein can be disabled and neutralized by trillions of electrons being generated per second. Device is Intended to disable virus particles in the air and on surfaces.

  • Extremely high-intensity discharge of electrons relies on precision design and geometry of the radiating surfaces in the device.

  • Our unique and innovative device intended for electron-mediated virus deactivation can be readily and cost-effectively manufactured to meet demand.

SHYCOCAN™ Retail Device

SHYCOCAN™ Retail Device

SHYCOCAN PERFORMANCE

  • 99.994% ( >4log10 ) reduction in a standard MS2 Bacteriophage decontamination assay

  • 99.963% reduction of an EPA-standard SARS-CoV-2 surrogate, in BSL-2 facilities.

  • Elimination of expectorated Influenza B viral loads, in BSL-2 facilities.

  • SARS-CoV-2 assays in enhanced BSL-3 facilities completed

  • Can be run 24/7 and operates on standard 110/240v wall outlet

  • Plug and play device with no setup required except for mounting on side wall, pedestal or table-top

  • Please refer to the SHYCOCAN FAQs for detailed information and answers to common questions as well as the Product Brief

Market Update

  • U.S. - Marketed under U.S. FDA Enforcement Discretion untill Nov 2023 (currently not marketed in the US)

  • European Union CE Mark as a Class I device

  • Marketing Strategies in place in CE compliant countries

  • Mexico and Latin America marketing and manufacturing strategy in place

Authorized Distributors - North/South America, Mexico, Caribbean

  • Shreis Scalene Therapeutics LLC (MD and VA, USA) - Exclusive marketing, manufacturing, and distribution of the Shreis Scalene SHYCOCAN® (currently not marketed in the US)

    • None of the other US distributors are currently authorized to market the SHYCOCAN® or alternate/renamed versions domestically within the US since November 2023.

  • Envirozyme (San Juan, Puerto Rico): Non-exclusive marketing and distribution of the Shreis Scalene SHYCOCAN®

  • Tres Monos Lab (Mexico City, Mexico): Non-exclusive distribution and product assembly of the Shreis Scalene SHYCOCAN® ( CE Class 1 medical device authorized for sale in Mexico)

  • BLT Inc. (Montreal, Canada): Non-exclusive marketing and distribution of the Shreis Scalene SHYCOCAN® (CE Class 1 medical device, authorized for sale under Health Canada-Class I designation.)

  • Kibovision (Santiago, Chile): Non-exclusive marketing and distribution of the Shreis Scalene SHYCOCAN® (CE Class 1 medical device, authorized for sale in LATAM countries).

  • Other LATAM distributors: Ongoing collaborations - Non-exclusive marketing and distribution of the Shreis Scalene SHYCOCAN®

  • Caribbean Countries: On-going collaborations- Non-exclusive marketing and distribution of the Shreis Scalene SHYCOCAN®

DISCLAIMER: No distributor can make any regulatory development statements on behalf of Shreis Scalene Therapeutics LLC that is not reflected in their agreement. No forward-looking statements are authorized under these agreements. All Distribution/marketing/assembly partners are routinely updated on the marketability of the SHYCOCAN® product in their respective regions. No misleading statements regarding the innovation, the ownership or the regulatory path forward can be claimed by any of the Distribution / Marketing / Product assembly partners. Use of any other name for the Product that has been agreed upon by Shreis, must be clearly labelled as ‘powered by the SHYCOCAN®’ for distribution within the respective territories, under prevailing market compliances.

Shipping Lead Times

SHYCOCAN UNITS WEEKS FOR PRODUCTION AND DELIVERY

1-10 Immediate Order Delivery

10 - 100 Immediate Order Delivery

101 - 1,000 4 - 6 weeks after Purchase

1,001 - 10,000 4 - 6 weeks after Purchase

10,001 - 100,000 30,000 units per month. Shipping by sea will be an additional 30 days

100,000 - 500,000 50,000 units per month and organize multiple centers to fulfill quantity in 4 months.

Shipping by sea will be an additional 30 days

Please note, these are estimated shipping times. Actual shipping times may vary based on production. Contact Shreis with any questions.

*See Resources for Product Brief, and FAQs for detailed information and answers to common questions regarding the SHYCOCAN®. For further information and inquiries, please Contact Us.

 

Global launch of SHYCOCAN® on August 14th 2020! Launched in 6 continents simultaneously - Asia, North America, South America, Europe, Africa, Australia!